SK pharmteco invests $260 million to construct newproduction facility for small molecules and peptides
October 2, 2024 | By Mary Bailey SK pharmteco (Seoul, South Koreaa), a global contract development and manufacturing organization (CDMO), announced a major expansion of its small molecule and peptide production capabilities with a $260 million investment …